| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Radiology, Nuclear Medicine & Medical Imaging |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei Yang, Kun Yan, S Nahum Goldberg, Muneeb Ahmed, Jung-Chieh Lee, Wei Wu, Zhong-Yi Zhang, Song Wang and Min-Hua Chen |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81471768 |
| Municipal Natural Science Foundation of Beijing of China |
7152031 |
| Beijing Municipal Health System Special Funds of High-Level Medical Personnel Construction |
2013-3-086 |
|
| Corresponding Author |
Min-Hua Chen, Professor, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Ultrasound, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Haidian District, Beijing 100142, China. minhuachen@vip.sina.com |
| Key Words |
Radiofrequency ablation; Hepatocellular carcinoma; Percutaneous; Ultrasonography-guided; Long term survival |
| Core Tip |
Numerous large series have shown that percutaneous radiofrequency ablation (RFA) is safe and effective, with minimal morbidity and mortality in hepatocellular carcinoma (HCC) treatment. However, few studies had follow-up time that was adequate to rival that of surgery and percutaneous ethanol injection. In our long-term follow-up study on a large group of HCC patients, we further confirmed that RFA could achieve a 10-year survival in HCC patients as a first-line treatment, especially for patients with liver function of Child-Pugh class A, a single tumor, and without portal vein hypertension. |
| Publish Date |
2016-03-04 19:53 |
| Citation |
Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 2016; 22(10): 2993-3005 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i10/2993.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i10.2993 |
